| Size & multiples | |||
| Market Cap | $77.0M | Enterprise Value | $268.6M |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.29× | P/FCF | 20.78× |
| EV/EBITDA | 6.85× | EV/EBIT | 32.35× |
| EV/Sales | 1.01× | EV/FCF | 72.51× |
| FCF Yield | 4.81% | Buyback Yield | — |
| Owner Earnings (TTM) | -$55.6M | Owner Earnings Yield | −72.26% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.91 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 8.55% |
| After-tax Cost of Debt | — | Synthetic credit rating | D |
| Cost of Debt · embedded (pre-tax) | 18.00% | Cost of Debt · marginal (synthetic) | 23.00% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF runs above owner earnings — under-maintenance or a working-capital release is flattering current cash.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.35 · revenue TTM $265.5M · FCF TTM $3.7M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on EV/EBITDA
EV/EBITDA 16th percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| EV/EBITDA | 7.2x | 15.1x | 9.8x–24.4x | 16 ↓cheap |
| FCF Yield | 2.1% | -7.8% | -34.7%–1.4% | 77 ↑strong |
| Net Margin | -26.1% | -21.2% | -325.3%–7.2% | 49 ↓weak |
| Operating Margin | 1.8% | -34.5% | -552.0%–8.0% | 68 ↑strong |
